Avalo Therapeutics, Inc. — 424B5 Filings
16 424B5 filings on record
This page lists all 424B5 filings submitted to the SEC by Avalo Therapeutics, Inc. (AVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Avalo Therapeutics, Inc. has filed 16 424B5 documents with the SEC since 2015. To view all SEC filings by Avalo Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | 424B5 | 0001628280-25-029637 | Jun 5, 2025 | — |
| 424B5 | 424B5 | 0001628280-23-027841 | Aug 7, 2023 | — |
| 424B5 | 424B5 | 0001628280-23-015810 | May 4, 2023 | — |
| 424B5 | 424B5 | 0001628280-23-002204 | Feb 3, 2023 | — |
| 424B5 | 424B5 | 0001628280-23-002040 | Feb 2, 2023 | — |
| 424B5 | 424B5 | 0001628280-21-018707 | Sep 15, 2021 | — |
| 424B5 | 424B5 | 0001628280-21-018573 | Sep 14, 2021 | — |
| 424B5 | 424B5 | 0001628280-21-013442 | Jul 2, 2021 | — |
| 424B5 | 424B5 | 0001628280-21-000319 | Jan 8, 2021 | — |
| 424B5 | 424B5 | 0001628280-21-000259 | Jan 7, 2021 | — |
| 424B5 | 424B5 | 0001628280-20-009170 | Jun 9, 2020 | — |
| 424B5 | 424B5 | 0001628280-20-009124 | Jun 8, 2020 | — |
| 424B5 | 424B5 | 0001047469-20-000688 | Feb 4, 2020 | — |
| 424B5 | 424B5 | 0001047469-19-000951 | Mar 6, 2019 | — |
| 424B5 | 424B5 | 0001047469-19-000913 | Mar 5, 2019 | — |
| 424B5 | 424B5 | 0001628280-17-000522 | Jan 27, 2017 | — |